Nautilus Biotechnology NAUT Stock
2.47 USD
{{ price }}
-6.083653%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
308.99M USD
LOW - HIGH [24H]
2.45
-
2.63 USD
VOLUME [24H]
72.72K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.51 USD
Nautilus Biotechnology Price Chart
Nautilus Biotechnology NAUT Financial and Trading Overview
| Nautilus Biotechnology stock price | 2.47 USD |
| Previous Close | 3.59 USD |
| Open | 3.6 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1200 |
| Day's Range | 3.6 - 3.98 USD |
| 52 Week Range | 1.5 - 3.98 USD |
| Volume | 109.21K USD |
| Avg. Volume | 100.26K USD |
| Market Cap | 495.72M USD |
| Beta (5Y Monthly) | 0.798941 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.51 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NAUT Valuation Measures
| Enterprise Value | 318.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.2688174 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.6324013 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.946 |
Trading Information
Nautilus Biotechnology Stock Price History
| Beta (5Y Monthly) | 0.798941 |
| 52-Week Change | 35.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.98 USD |
| 52 Week Low | 1.5 USD |
| 50-Day Moving Average | 2.72 USD |
| 200-Day Moving Average | 2.21 USD |
NAUT Share Statistics
| Avg. Volume (3 month) | 100.26K USD |
| Avg. Daily Volume (10-Days) | 127.15K USD |
| Shares Outstanding | 124.87M |
| Float | 37.51M |
| Short Ratio | 9.52 |
| % Held by Insiders | 41.10% |
| % Held by Institutions | 37.14% |
| Shares Short | 591.7K |
| Short % of Float | 1.05% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.23% |
| Return on Equity (ttm) | -17.48% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -64335000 USD |
| Net Income Avi to Common (ttm) | -57126000 USD |
| Diluted EPS (ttm) | -0.45 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 167.35M USD |
| Total Cash Per Share (mrq) | 1.34 USD |
| Total Debt (mrq) | 37.31M USD |
| Total Debt/Equity (mrq) | 12.28 USD |
| Current Ratio (mrq) | 21.501 |
| Book Value Per Share (mrq) | 2.432 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -45995000 USD |
| Levered Free Cash Flow (ttm) | -28902000 USD |
Profile of Nautilus Biotechnology
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 2701 Eastlake Avenue East |
| ZIP | 98102 |
| Phone | 206 333 2001 |
| Website | https://www.nautilus.bio |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 153 |
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.
Q&A For Nautilus Biotechnology Stock
What is a current NAUT stock price?
Nautilus Biotechnology NAUT stock price today per share is 2.47 USD.
How to purchase Nautilus Biotechnology stock?
You can buy NAUT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nautilus Biotechnology?
The stock symbol or ticker of Nautilus Biotechnology is NAUT.
Which industry does the Nautilus Biotechnology company belong to?
The Nautilus Biotechnology industry is Biotechnology.
How many shares does Nautilus Biotechnology have in circulation?
The max supply of Nautilus Biotechnology shares is 125.1M.
What is Nautilus Biotechnology Price to Earnings Ratio (PE Ratio)?
Nautilus Biotechnology PE Ratio is now.
What was Nautilus Biotechnology earnings per share over the trailing 12 months (TTM)?
Nautilus Biotechnology EPS is -0.51 USD over the trailing 12 months.
Which sector does the Nautilus Biotechnology company belong to?
The Nautilus Biotechnology sector is Healthcare.
Nautilus Biotechnology NAUT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}